These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12784658

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Splenic lymphoma with villous lymphocytes: morphologic, immunologic and molecular study. Report of three cases].
    Labouyrie E, Chartois-Leauté AG, Dubus P, Duchayne E, Brousset P, Ceccaldi J, Capbern M, Fialon P, Soubeyran P, Delsol G, de Mascarel A, Merlio JP.
    Ann Pathol; 1996 Sep; 16(4):285-91. PubMed ID: 9172620
    [Abstract] [Full Text] [Related]

  • 23. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.
    Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I.
    Clin Immunol; 2007 Feb; 122(2):139-45. PubMed ID: 17008130
    [Abstract] [Full Text] [Related]

  • 24. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
    Imamura T, Yoshihara T, Morimoto A, Ishida H, Sugimoto T, Imashuku S.
    Pediatr Hematol Oncol; 2006 Feb; 23(1):19-24. PubMed ID: 16326408
    [Abstract] [Full Text] [Related]

  • 25. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K, Prins C, Saurat JH, French LE.
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H, Hawley I, Beard J.
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S, Kalla H, Balasubramanian M, Brodsky I, Gladstone D, Hou JS.
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [Abstract] [Full Text] [Related]

  • 30. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
    Dincol G, Agan M, Dogan O, Diz-Kucukkaya R, Uslu B.
    Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
    [Abstract] [Full Text] [Related]

  • 31. Splenic marginal zone lymphoma: transformation to diffuse large B-cell lymphoma with isolated cerebral manifestation.
    Thoennissen NH, Keyvani K, Voelker HU, Bremer J, Krug U, Müller-Tidow C, Koch P, Müller-Hermelink HK, Berdel WE.
    J Clin Oncol; 2008 Sep 20; 26(27):4509-11. PubMed ID: 18802164
    [No Abstract] [Full Text] [Related]

  • 32. [Splenic lymphoma with villous lymphocytes expressing chromosomal abnormalities].
    Fujita M, Uno H, Hino N, Nakagawa H, Nagaoka K, Sasaki N.
    Rinsho Ketsueki; 1999 Apr 20; 40(4):330-5. PubMed ID: 10355143
    [Abstract] [Full Text] [Related]

  • 33. Primary splenic B-cell lymphoma (marginal zone lymphoma). Clinicopathological evaluation of 10 cases.
    Maryniak RK, Prochorec-Sobieszek M.
    Pol J Pathol; 2000 Apr 20; 51(4):185-90. PubMed ID: 11247389
    [Abstract] [Full Text] [Related]

  • 34. [Splenic marginal zone lymphoma. One case report].
    El Mezni F, Zeddini A, Ismail O, Braham E.
    Tunis Med; 2005 Jun 20; 83(6):366-8. PubMed ID: 16156414
    [Abstract] [Full Text] [Related]

  • 35. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, Patey M, Rousselet MC, Bene MC, Damotte D, Cornillet Lefebvre P, Martin A, Costes V, GOELAMS group.
    Hum Pathol; 2008 Feb 20; 39(2):194-200. PubMed ID: 17949786
    [Abstract] [Full Text] [Related]

  • 36. A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes.
    Oyaizu N, Kozai Y, Kodo H, Sunaga S, Iwabuchi K, Higashihara M, Mori S.
    Acta Haematol; 2005 Feb 20; 113(3):194-7. PubMed ID: 15870490
    [Abstract] [Full Text] [Related]

  • 37. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P.
    Cancer Chemother Pharmacol; 2009 Mar 20; 63(4):759-60. PubMed ID: 18500519
    [No Abstract] [Full Text] [Related]

  • 38. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T, Jaén-Martínez J, Gumá-Padró J, Bosch-Príncep R, Salvadó-Usach MT.
    Ann Hematol; 2003 Sep 20; 82(9):585-8. PubMed ID: 12898184
    [Abstract] [Full Text] [Related]

  • 39. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
    Shirao S, Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Konuma Y, Hirayama Y, Kohda K.
    Rinsho Ketsueki; 2006 Mar 20; 47(3):204-9. PubMed ID: 16629485
    [Abstract] [Full Text] [Related]

  • 40. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
    Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, A'Hern R, Delgado J, Bazerbashi MB, Catovsky D.
    Haematologica; 2004 Mar 20; 89(3):303-8. PubMed ID: 15020268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.